An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Počki(2022)

引用 0|浏览0
暂无评分
摘要
No abstract
更多
查看译文
关键词
dominant polycystic kidney disease,inherited kidney disorders,tolvaptan
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要